Literature DB >> 12814592

Optimized EPI for fMRI studies of the orbitofrontal cortex.

R Deichmann1, J A Gottfried, C Hutton, R Turner.   

Abstract

A common problem in gradient-echo echo planar imaging (EPI) is the occurrence of image distortions and signal losses caused by susceptibility gradients near air/tissue interfaces. Since EPI is frequently used for functional magnetic resonance imaging experiments based on the blood oxygenation level-dependent effect, functional studies of certain brain regions affected by susceptibility gradients, such as the temporal lobes and the orbitofrontal cortex, may be compromised. In this work a method for signal recovery in certain regions of the orbitofrontal cortex is presented. The influence of in-plane susceptibility gradients is reduced by optimization of the imaging slice orientation. Through-plane susceptibility gradients are partly compensated by means of a moderate preparation gradient pulse similar to z-shimming. In contrast to several other techniques proposed in the literature for reducing susceptibility effects, this method does not compromise the temporal resolution and is therefore applicable to event-related studies.

Mesh:

Year:  2003        PMID: 12814592     DOI: 10.1016/s1053-8119(03)00073-9

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  351 in total

1.  Distinct neural substrates for semantic knowledge and naming in the temporoparietal network.

Authors:  Benno Gesierich; Jorge Jovicich; Marianna Riello; Michela Adriani; Alessia Monti; Valentina Brentari; Simon D Robinson; Stephen M Wilson; Scott L Fairhall; Maria Luisa Gorno-Tempini
Journal:  Cereb Cortex       Date:  2011-11-02       Impact factor: 5.357

2.  Comparing apples and oranges: using reward-specific and reward-general subjective value representation in the brain.

Authors:  Dino J Levy; Paul W Glimcher
Journal:  J Neurosci       Date:  2011-10-12       Impact factor: 6.167

3.  The embodiment of emotional feelings in the brain.

Authors:  Neil A Harrison; Marcus A Gray; Peter J Gianaros; Hugo D Critchley
Journal:  J Neurosci       Date:  2010-09-22       Impact factor: 6.167

Review 4.  Motivational Deficits in Schizophrenia and the Representation of Expected Value.

Authors:  James A Waltz; James M Gold
Journal:  Curr Top Behav Neurosci       Date:  2016

5.  Healthy co-twins of patients with affective disorders show reduced risk-related activation of the insula during a monetary gambling task.

Authors:  Julian Macoveanu; Kamilla Miskowiak; Lars V Kessing; Maj Vinberg; Hartwig R Siebner
Journal:  J Psychiatry Neurosci       Date:  2016-01       Impact factor: 6.186

6.  Threat-related amygdala functional connectivity is associated with 5-HTTLPR genotype and neuroticism.

Authors:  Martin Korsbak Madsen; Brenda Mc Mahon; Sofie Bech Andersen; Hartwig Roman Siebner; Gitte Moos Knudsen; Patrick MacDonald Fisher
Journal:  Soc Cogn Affect Neurosci       Date:  2015-08-04       Impact factor: 3.436

7.  Affective value and associative processing share a cortical substrate.

Authors:  Amitai Shenhav; Lisa Feldman Barrett; Moshe Bar
Journal:  Cogn Affect Behav Neurosci       Date:  2013-03       Impact factor: 3.282

8.  Anterolateral prefrontal cortex mediates the analgesic effect of expected and perceived control over pain.

Authors:  Katja Wiech; Raffael Kalisch; Nikolaus Weiskopf; Burkhard Pleger; Klaas Enno Stephan; Raymond J Dolan
Journal:  J Neurosci       Date:  2006-11-01       Impact factor: 6.167

9.  Reappraisal of incentives ameliorates choking under pressure and is correlated with changes in the neural representations of incentives.

Authors:  Simon Dunne; Vikram S Chib; Joseph Berleant; John P O'Doherty
Journal:  Soc Cogn Affect Neurosci       Date:  2019-01-04       Impact factor: 3.436

10.  Neurocomputational mechanisms of prosocial learning and links to empathy.

Authors:  Patricia L Lockwood; Matthew A J Apps; Vincent Valton; Essi Viding; Jonathan P Roiser
Journal:  Proc Natl Acad Sci U S A       Date:  2016-08-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.